PRO: Maintenance Therapy Is Superior to Episodic Therapy

Lichtenstein, Gary R.

doi:10.1111/j.1572-0241.2005.50622_1.x

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2006

2011

Publication Types

Select...

Article4

Book1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 15 publications

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Practical application of anti-TNF therapy for luminal Crohnʼs disease

Kamm

Cruz

et al. 2011

Inflammatory Bowel Diseases

View full text Add to dashboard Cite

Anti-tumor necrosis factor (TNF) therapy to treat inflammatory bowel disease has been available for more than a decade. Although extensive data on the outcome of anti-TNF therapy from individual clinical trials and patient cohorts are available, integrated guidance on the best use of such therapy to achieve optimal clinical outcomes when managing patients with luminal Crohn's disease is lacking. This review combines published data to establish practical strategies for anti-TNF therapy with respect to effective and safe timing of introduction, use of concurrent immunosuppressive therapy, dose escalation, managing relapse, changing drugs, pregnancy and breast feeding, and stopping drug treatment.

show abstract